Levobetaxolol is a beta-blocker used to lower the pressure in the eye to treat conditions such as glaucoma. It was marketed as a 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon but has been discontinued.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Levobetaxolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Levobetaxolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Levobetaxolol. |
| Amiodarone | The therapeutic efficacy of Levobetaxolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Levobetaxolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Levobetaxolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Levobetaxolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Levobetaxolol. |
| Fingolimod | Levobetaxolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Levobetaxolol. |
| Methacholine | Levobetaxolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Levobetaxolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Levobetaxolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Levobetaxolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Levobetaxolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Levobetaxolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Levobetaxolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Levobetaxolol. |
| Rivastigmine | Levobetaxolol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Levobetaxolol can be increased when it is combined with Mirabegron. |
| Insulin argine | Levobetaxolol may increase the hypoglycemic activities of Insulin argine. |
| Nicotine | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Nicotine. |
| Cevimeline | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Cevimeline. |
| Carbamoylcholine | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Carbamoylcholine. |
| Bethanechol | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Bethanechol. |
| Pilocarpine | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Pilocarpine. |
| Varenicline | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Varenicline. |
| Acetylcholine | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Acetylcholine. |
| Arecoline | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Arecoline. |
| Lobeline | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Lobeline. |
| NGX267 | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with NGX267. |
| GTS-21 | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with GTS-21. |
| Epibatidine | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Epibatidine. |
| Xanomeline | The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Xanomeline. |
| Thiethylperazine | The serum concentration of Levobetaxolol can be increased when it is combined with Thiethylperazine. |
| Promazine | The serum concentration of Levobetaxolol can be increased when it is combined with Promazine. |
| Prochlorperazine | The serum concentration of Levobetaxolol can be increased when it is combined with Prochlorperazine. |
| Triflupromazine | The serum concentration of Levobetaxolol can be increased when it is combined with Triflupromazine. |
| Fluphenazine | The serum concentration of Levobetaxolol can be increased when it is combined with Fluphenazine. |
| Moricizine | The serum concentration of Levobetaxolol can be increased when it is combined with Moricizine. |
| Trifluoperazine | The serum concentration of Levobetaxolol can be increased when it is combined with Trifluoperazine. |
| Perphenazine | The serum concentration of Levobetaxolol can be increased when it is combined with Perphenazine. |
| Mesoridazine | The serum concentration of Levobetaxolol can be increased when it is combined with Mesoridazine. |
| Acetophenazine | The serum concentration of Levobetaxolol can be increased when it is combined with Acetophenazine. |
| Promethazine | The serum concentration of Levobetaxolol can be increased when it is combined with Promethazine. |
| Alimemazine | The serum concentration of Levobetaxolol can be increased when it is combined with Alimemazine. |
| Periciazine | The serum concentration of Levobetaxolol can be increased when it is combined with Periciazine. |
| Acepromazine | The serum concentration of Levobetaxolol can be increased when it is combined with Acepromazine. |
| Aceprometazine | The serum concentration of Levobetaxolol can be increased when it is combined with Aceprometazine. |
| Pipotiazine | The serum concentration of Levobetaxolol can be increased when it is combined with Pipotiazine. |
| Thioproperazine | The serum concentration of Levobetaxolol can be increased when it is combined with Thioproperazine. |
| BL-1020 | The serum concentration of Levobetaxolol can be increased when it is combined with BL-1020. |
| Cyamemazine | The serum concentration of Levobetaxolol can be increased when it is combined with Cyamemazine. |
| Methylene blue | The serum concentration of Levobetaxolol can be increased when it is combined with Methylene blue. |
| Propiopromazine | The serum concentration of Levobetaxolol can be increased when it is combined with Propiopromazine. |
| Perazine | The serum concentration of Levobetaxolol can be increased when it is combined with Perazine. |
| Butaperazine | The serum concentration of Levobetaxolol can be increased when it is combined with Butaperazine. |
| Chlorproethazine | The serum concentration of Levobetaxolol can be increased when it is combined with Chlorproethazine. |
| Thiazinam | The serum concentration of Levobetaxolol can be increased when it is combined with Thiazinam. |
| Dixyrazine | The serum concentration of Levobetaxolol can be increased when it is combined with Dixyrazine. |
| Perphenazine enanthate | The serum concentration of Levobetaxolol can be increased when it is combined with Perphenazine enanthate. |
| Digoxin | Levobetaxolol may increase the bradycardic activities of Digoxin. |
| Acetyldigitoxin | Levobetaxolol may increase the bradycardic activities of Acetyldigitoxin. |
| Deslanoside | Levobetaxolol may increase the bradycardic activities of Deslanoside. |
| Ouabain | Levobetaxolol may increase the bradycardic activities of Ouabain. |
| Digitoxin | Levobetaxolol may increase the bradycardic activities of Digitoxin. |
| Oleandrin | Levobetaxolol may increase the bradycardic activities of Oleandrin. |
| Cymarin | Levobetaxolol may increase the bradycardic activities of Cymarin. |
| Proscillaridin | Levobetaxolol may increase the bradycardic activities of Proscillaridin. |
| Metildigoxin | Levobetaxolol may increase the bradycardic activities of Metildigoxin. |
| Lanatoside C | Levobetaxolol may increase the bradycardic activities of Lanatoside C. |
| Gitoformate | Levobetaxolol may increase the bradycardic activities of Gitoformate. |
| Acetyldigoxin | Levobetaxolol may increase the bradycardic activities of Acetyldigoxin. |
| Peruvoside | Levobetaxolol may increase the bradycardic activities of Peruvoside. |
| Lidocaine | The serum concentration of Lidocaine can be increased when it is combined with Levobetaxolol. |
| Icosapent | Icosapent may decrease the antihypertensive activities of Levobetaxolol. |
| Mesalazine | The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Levobetaxolol. |
| Indomethacin | Indomethacin may decrease the antihypertensive activities of Levobetaxolol. |
| Nabumetone | Nabumetone may decrease the antihypertensive activities of Levobetaxolol. |
| Ketorolac | Ketorolac may decrease the antihypertensive activities of Levobetaxolol. |
| Tenoxicam | Tenoxicam may decrease the antihypertensive activities of Levobetaxolol. |
| Celecoxib | Celecoxib may decrease the antihypertensive activities of Levobetaxolol. |
| Tolmetin | Tolmetin may decrease the antihypertensive activities of Levobetaxolol. |
| Rofecoxib | Rofecoxib may decrease the antihypertensive activities of Levobetaxolol. |
| Piroxicam | Piroxicam may decrease the antihypertensive activities of Levobetaxolol. |
| Fenoprofen | Fenoprofen may decrease the antihypertensive activities of Levobetaxolol. |
| Valdecoxib | Valdecoxib may decrease the antihypertensive activities of Levobetaxolol. |
| Diclofenac | Diclofenac may decrease the antihypertensive activities of Levobetaxolol. |
| Sulindac | Sulindac may decrease the antihypertensive activities of Levobetaxolol. |
| Flurbiprofen | Flurbiprofen may decrease the antihypertensive activities of Levobetaxolol. |
| Etodolac | Etodolac may decrease the antihypertensive activities of Levobetaxolol. |
| Mefenamic acid | Mefenamic acid may decrease the antihypertensive activities of Levobetaxolol. |
| Naproxen | Naproxen may decrease the antihypertensive activities of Levobetaxolol. |
| Sulfasalazine | Sulfasalazine may decrease the antihypertensive activities of Levobetaxolol. |
| Phenylbutazone | Phenylbutazone may decrease the antihypertensive activities of Levobetaxolol. |
| Meloxicam | Meloxicam may decrease the antihypertensive activities of Levobetaxolol. |
| Carprofen | Carprofen may decrease the antihypertensive activities of Levobetaxolol. |
| Diflunisal | Diflunisal may decrease the antihypertensive activities of Levobetaxolol. |
| Salicylic acid | Salicylic acid may decrease the antihypertensive activities of Levobetaxolol. |